(Q39971560)

16 September 2017

title

Hepatitis C infection among injection drug users in Stockholm Sweden: prevalence and gender (English)

1 reference

16 September 2017

0 references

1 reference

Soo Aleman

6

0 references

Johan Franck

5

object named as

Johan Franck

1 reference

16 September 2017

Christer Lidman

1

1 reference

16 September 2017

Lillebil Norden

2

1 reference

16 September 2017

Martin Kåberg

3

1 reference

16 September 2017

Kerstin Käll

4

1 reference

16 September 2017

Markus Birk

7

1 reference

16 September 2017

publication date

1 January 2009

1 reference

16 September 2017

1 reference

16 September 2017

volume

41

1 reference

16 September 2017

issue

9

1 reference

16 September 2017

page(s)

679-684

1 reference

Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

High hepatitis C incidence in new injecting drug users: a policy failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

The epidemiology of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

Sexually acquired hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

A significant sex--but not elective cesarean section--effect on mother-to-child transmission of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

Hepatitis C virus seroconversion among young injection drug users: relationships and risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

Gender differences in the initiation of injection drug use among young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

Gender differences in injection risk behaviors at the first injection episode.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

Gender differences in HIV risk behaviors among young injectors and their social network members

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

Gender differences in sharing injecting equipment by drug users in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

Molecular epidemiology of hepatitis C virus infection among intravenous drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

Distribution of hepatitis C virus genotypes among injecting drug users in contact with treatment centers in Belgium, 2004-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

Development of a microfluidic platform with an optical imaging microarray capable of attomolar target DNA detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

Health service utilization and benzodiazepine use among heroin users: findings from the Australian Treatment Outcome Study (ATOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

The antibody response to hepatitis B virus vaccination is negatively influenced by the hepatitis C virus viral load in patients with chronic hepatitis C: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540903062143

10.1080/00365540903062143

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference